compulsorily convertible preference shares
Biocon concludes Viatris' $3 bn acquisition
Biosimilars manufacturing arm of Biocon Ltd, Biocon Biologics, on Tuesday announced completion of acquisition of Viatris' global biosimilars business for ......
CDPQ becomes 20% equity owner in Edelweiss ARC
CDPQ Private Equity Asia has picked up a 20% equity stake in Edelweiss Asset Reconstruction Company Ltd (EARC), Edelweiss said ......
Recommended for you